HGF and cancer: In CRLM, heparan sulfate proteoglycans, such as syndecan-1 and glypican-3, facilitate cancer cell proliferation and metastasis by sequestering growth factors like hepatocyte growth factor (HGF) and fibroblast growth factor (FGF), which activate pro-tumorigenic pathways.